Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Rainer H. Kohler, Ph.D.

Co-Author

This page shows the publications co-authored by Rainer Kohler and Katherine Yang.
Connection Strength

0.438
  1. Single cell resolution in vivo imaging of DNA damage following PARP inhibition. Sci Rep. 2015 May 18; 5:10129.
    View in: PubMed
    Score: 0.161
  2. In vivo imaging reveals a tumor-associated macrophage-mediated resistance pathway in anti-PD-1 therapy. Sci Transl Med. 2017 05 10; 9(389).
    View in: PubMed
    Score: 0.046
  3. Predicting therapeutic nanomedicine efficacy using a companion magnetic resonance imaging nanoparticle. Sci Transl Med. 2015 Nov 18; 7(314):314ra183.
    View in: PubMed
    Score: 0.042
  4. Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug. Nat Commun. 2015 Oct 27; 6:8692.
    View in: PubMed
    Score: 0.042
  5. Optimized Near-IR Fluorescent Agents for in Vivo Imaging of Btk Expression. Bioconjug Chem. 2015 Aug 19; 26(8):1513-8.
    View in: PubMed
    Score: 0.040
  6. Effect of small-molecule modification on single-cell pharmacokinetics of PARP inhibitors. . 2014 Apr; 13(4):986-95.
    View in: PubMed
    Score: 0.037
  7. Platinum compounds for high-resolution in vivo cancer imaging. ChemMedChem. 2014 Jun; 9(6):1131-5.
    View in: PubMed
    Score: 0.037
  8. Imaging therapeutic PARP inhibition in vivo through bioorthogonally developed companion imaging agents. Neoplasia. 2012 Mar; 14(3):169-77.
    View in: PubMed
    Score: 0.032
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.